Senate Committee Looks at 340B
Last week the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on the 340B Drug Pricing Program, which provides discounted prescription drugs to eligible health care providers, known as "covered entities," to help them serve low-income and uninsured patients. In recent years the 340B program has become more controversial as it has grown and as pharmaceutical companies object more strenuously to the discounts they are required to provide to participating providers. In addition, some critics charge that the savings providers gain from 340B discounts are not consistently reinvested in care for low-income and uninsured patients while those [...]
